跳至主要内容
临床试验/JPRN-jRCTs071180092
JPRN-jRCTs071180092招募中2 期

Efficacy and safety of pyrimethamine/sulfadiazine/folinate combination therapy for the treatment of ocular toxoplasmosis - Treatment of ocular toxoplasmosis with pyrimethamine/sulfadiazine

Maruyama Haruhiko0 个研究点目标入组 35 人开始时间: 2019年3月29日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • Patients with active uveitis and one of the following findings
  • #1 Toxoplasma DNA positive
  • #2 high anti-Toxoplasma IgG concentration in vitreous humor
  • #3 serum anti-Toxoplasma IgG positive

排除标准

  • #1 HIV positive patients
  • #2 patients allergic to test compounds
  • #3 patients with megaloblastic anemia due to
  • folate deficiency
  • #4 No consent is given from the patient
  • him/herself nor a legally authorized
  • representative/guardian of the patient
  • #5 patients principal investigator judged
  • inappropriate

研究者

发起方
Maruyama Haruhiko

相似试验